Compounds > pantoprazole

pantoprazole and alendronate

pantoprazole has been researched along with alendronate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Kozyrskyj, A; Racher, A; Raymond, C1
Cegieła, U; Folwarczna, J; Nowińska, B; Pytlik, M1

Reviews

1 review(s) available for pantoprazole and alendronate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for pantoprazole and alendronate

ArticleYear
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Alendronate; Attitude of Health Personnel; Celecoxib; Clopidogrel; Data Collection; Diffusion of Innovation; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Insurance, Health, Reimbursement; Male; Manitoba; Middle Aged; Pantoprazole; Practice Patterns, Physicians'; Pyrazoles; Socioeconomic Factors; Sulfonamides; Ticlopidine; Time Factors

2007
Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Drug Interactions; Estrogens; Female; Femur; Omeprazole; Ovariectomy; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Tibia

2012